Aptevo Therapeutics Inc (NQ: APVO )

6.460 USD -0.130 (-1.97%)

Official Closing Price Updated: 4:00 PM EDT, Oct 30, 2020 Add to My Watchlist

Price and Volume

Volume	18,900
Open	6.495
Bid (Size)	6.000 (11)
Ask (Size)	6.570 (2)
Prev. Close	6.590
Today's Range	6.360 - 6.569
52wk Range	0.2103 - 11.73
Shares Outstanding	22,586,132
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial

September 01, 2020

Aptevo Therapeutics Reports Second Quarter 2020 Financial Results

August 14, 2020

Performance

YTD	+909.38%	+909.38%
1 Month	-15.00%	-15.00%
3 Month	-23.10%	-23.10%
6 Month	+23.05%	+23.05%
1 Year	+1058.95%	+1058.95%

More News

Aptevo Therapeutics Secures $25 Million Non-Dilutive Financing from Midcap Financial Trust

August 06, 2020

Aptevo Therapeutics Engages Piper Sandler to Sell its RUXIENCE(R) and IXINITY(R) Royalty Streams & Milestones

July 21, 2020

Aptevo Therapeutics Collects $750,000 Working Capital Escrow From Medexus Related to IXINITY(R) Sale

June 29, 2020

Aptevo Therapeutics to receive Seven Year Quarterly Royalty Payment Stream from Pfizer for Sales of Rituximab Biosimilar

June 25, 2020

Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit

June 10, 2020

Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit

June 10, 2020

12 Healthcare Stocks Moving In Thursday's After-Market Session

October 08, 2020

Aptevo Therapeutics Reports First Quarter 2020 Financial Results

May 13, 2020

Mid-Afternoon Market Update: US Stocks Mostly Flat; Ekso Bionics Shares Spike Higher

June 25, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.